Company Filing History:
1 out of 11 
1 out of 5,094 
Years Active: 2012
Title: Roza Kucharczyk: Innovator in Mitochondrial Research
Introduction
Roza Kucharczyk is a notable inventor based in Warsaw, Poland. He has made significant contributions to the field of mitochondrial research, particularly in relation to NARP syndrome. His innovative work has led to the development of a patent that addresses critical health issues associated with mitochondrial deficiencies.
Latest Patents
Roza Kucharczyk holds a patent for "Modified yeast cells comprising at least one mutation of the tryptophan 136 (W), leucine 183 (L), or leucine 247 (L) codon of the mitochondrial ATP6 gene." This invention is particularly relevant for screening medicaments that combat mitochondrial pathologies, including NARP syndrome. His patent is a crucial step towards understanding and potentially treating conditions that involve deficiencies in ATP production via the oxidative phosphorylation pathway. He has 1 patent to his name.
Career Highlights
Throughout his career, Roza has worked with esteemed institutions such as Université Victor Segalen—Bordeaux 2 and the Centre National de la Recherche Scientifique. His research has been instrumental in advancing the understanding of mitochondrial diseases and their implications for human health.
Collaborations
Roza has collaborated with notable colleagues, including Jean-Paul Di Rago and Malgorzata Rak. Their combined expertise has contributed to the success of various research initiatives in the field of mitochondrial genetics.
Conclusion
Roza Kucharczyk's innovative work in mitochondrial research highlights the importance of scientific inquiry in addressing complex health issues. His contributions pave the way for future advancements in the treatment of mitochondrial pathologies.